Nexplanon Does Not Clinically Affect TSH Levels
Nexplanon (etonogestrel implant) causes only minimal, transient changes in thyroid function tests that have no clinical significance in healthy women. According to the FDA drug label, thyroxine concentrations may initially be slightly decreased following insertion, but gradually recover to baseline 1.
Evidence from Clinical Studies
Research directly examining Nexplanon's effect on thyroid function demonstrates:
A 3-year prospective study of 70 women found no statistically significant differences in TSH, free T3, or free T4 levels between baseline and end-of-study measurements 2. All thyroid parameters remained within normal ranges throughout the study period.
A 2-year comparative study of 80 implant users showed that etonogestrel implants may induce minimal changes in thyroid hormones, likely secondary to alterations in binding globulins rather than actual thyroid dysfunction 3. Importantly, these changes had no clinical significance in healthy women.
Mechanism and Clinical Implications
The minimal thyroid changes observed are attributed to:
- Alterations in thyroid-binding globulin concentrations rather than true thyroid dysfunction
- Initial slight decreases in total thyroxine concentrations that normalize over time
- No impact on TSH levels or free hormone concentrations that would indicate clinical hypothyroidism or hyperthyroidism
Practical Recommendations
For routine contraceptive use:
- No baseline thyroid testing is required before Nexplanon insertion in healthy women 4
- Routine monitoring of thyroid function during Nexplanon use is unnecessary
- Women can be reassured that the implant does not cause clinically meaningful thyroid dysfunction
For women with pre-existing thyroid disease:
- Continue standard thyroid monitoring based on their underlying condition, not because of Nexplanon
- Nexplanon does not interfere with thyroid hormone replacement therapy
- The implant remains an appropriate contraceptive option for women with controlled thyroid disease
Important caveat: While animal studies suggest progestins may affect thyroid function through upregulation of TSH receptors 5, these findings have not translated to clinically significant effects in human studies with etonogestrel implants.